Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.600
+0.060 (1.32%)
Aug 6, 2026, 10:30 AM EDT - Market open

Prelude Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
45618370234289593
Market Cap Growth
624.79%160.66%-70.13%-18.95%-51.18%-81.05%
Enterprise Value
386.4397.14-45.5521.7889.41303.16
Last Close Price
4.602.901.274.276.0412.45

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
26.9315.0410.01---
PB Ratio
6.232.660.530.991.482.07
P/TBV Ratio
6.013.250.731.091.462.01

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
23.118.00-6.51---
EV/EBITDA Ratio
--0.33---
EV/EBIT Ratio
--0.33---
EV/FCF Ratio
--0.44---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.250.220.120.0800
Net Debt / Equity Ratio
-1.06-1.25-0.88-0.90-1.02-1.01
Net Debt / EBITDA Ratio
0.770.830.841.621.642.57
Net Debt / FCF Ratio
1.461.521.121.922.303.37
Asset Turnover
-0.080.03000
Quick Ratio
1.951.955.2110.679.3015.17
Current Ratio
2.031.995.3010.799.4215.37
Return on Equity (ROE)
-120.79%-99.45%-69.01%-56.34%-47.97%-44.85%
Return on Assets (ROA)
-64.48%-66.01%-61.66%-53.11%-47.01%-43.03%
Return on Invested Capital (ROIC)
-220.90%-259.19%-325.38%-430.11%-832.62%-1568.33%
Return on Capital Employed (ROCE)
-101.22%-87.80%-68.87%-58.19%-50.98%-45.67%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-3.59%-1.52%-25.60%-27.41%-2.87%-269.03%
Total Shareholder Return
-3.59%-1.52%-25.60%-27.41%-2.87%-269.03%
SEC Filings: 10-K · 10-Q